
Images are for product identification. Refer to the selected batch for packaging and availability.
Novomix 30 Flexpen 100 Iu Inj 3 Ml Pen
Insulin Aspart undefined (30%) + undefined Insulin Aspart Protamine (70%)
YOUR PURCHASE PRICE
12 in stockInclusive of all taxes
Available batch
1 offerSign in to order for your pharmacy.
Product information
- Manufacturer
- Abbott India Limited (novo Nordisk)
- Category
- Allopathy
- Composition
- Insulin Aspart undefined (30%) + undefined Insulin Aspart Protamine (70%)
- Packaging
- 3 ML
- Box / case pack
- 1 / —
Description
NOVOMIX 30 FLEXPEN 100 IU INJ 3 ML PEN
NovoMix 30 FlexPen is a modern insulin (insulin analogue) product designed for managing diabetes mellitus.
-
Name:
- Brand Name: NovoMix 30 FlexPen
- Common Name: Insulin Aspart (biphasic insulin aspart 30)
-
Composition: NovoMix 30 FlexPen contains 100 units of insulin aspart per ml. It is a pre-mixed neutral suspension composed of 30% rapid-acting insulin aspart and 70% longer-acting protamine insulin aspart. Each pre-filled pen contains 3 ml, totaling 300 units.
-
Uses: NovoMix 30 FlexPen is prescribed for the treatment of diabetes mellitus in adults, adolescents, and children aged 10 years and above. It helps lower high blood sugar levels in individuals with both Type 1 and Type 2 diabetes. It can be used as monotherapy or in combination with oral antidiabetic medications or GLP-1 receptor agonists.
-
Dosage and Administration: This medicine is administered as a subcutaneous injection, typically into the abdomen, thighs, buttocks, or upper arms. Injection sites should be rotated regularly within the same region. It is generally taken immediately (up to 10 minutes) before a meal, or shortly after starting a meal if necessary. Dosage is individualized by a physician. For Type 2 diabetes, a common starting regimen is 6 units at breakfast and 6 units at dinner, or 12 units once daily at dinner. The FlexPen can deliver doses from 1 to 60 units in 1-unit increments. It must not be injected intravenously or intramuscularly, nor used in insulin pumps.
-
Side Effects: The most common side effect is low blood sugar (hypoglycemia), which can be severe. Other common effects include local reactions at the injection site (pain, redness, bruising, swelling, itching), lipodystrophy (skin thickening or pitting), or cutaneous amyloidosis (lumps under the skin). Weight gain and temporary vision problems may also occur. Serious but rare side effects include systemic allergic reactions.
-
Precautions: Do not use if allergic to insulin aspart or any excipients. Patients should be educated on recognizing and treating hypoglycemia; alcohol consumption may mask symptoms. Close monitoring is crucial for patients with kidney, liver, or gland disorders. Caution is advised when driving or operating machinery due to potential blood sugar fluctuations. Consult a doctor if pregnant or breastfeeding. Various medications can interact with insulin, necessitating dose adjustments.
-
Storage: Unused NovoMix 30 FlexPen should be stored in a refrigerator (2°C–8°C), away from the freezer element, and must not be frozen. In-use or spare pens should not be refrigerated but can be kept at room temperature (below 30°C) for up to 4 weeks, after which they must be discarded. Protect the pen from excessive heat and light by keeping the cap on when not in use. Do not use if frozen or if the suspension is not uniformly white and cloudy after resuspension. Keep out of reach of children.
Frequently asked questions
NOVOMIX 30 FLEXPEN 100 IU INJ 3 ML PEN by ABBOTT INDIA LIMITED (NOVO NORDISK)
What is NovoMix 30 FlexPen used for?
NovoMix 30 FlexPen is an insulin analogue used to treat diabetes mellitus in adults, adolescents, and children aged 10 years and above. Diabetes is a condition where the body does not produce enough insulin to control blood sugar levels. NovoMix 30 helps to lower high blood sugar.
How does NovoMix 30 FlexPen work?
NovoMix 30 is a pre-mixed suspension containing 30% rapid-acting insulin aspart and 70% longer-acting protamine insulin aspart. The rapid-acting component starts to lower blood sugar within 10 to 20 minutes, with its maximum effect occurring between 1 and 4 hours after injection. The longer-acting component provides an effect that can last for up to 24 hours, helping to control blood sugar throughout the day.
What is the usual dosage for NovoMix 30 FlexPen?
The dosage of NovoMix 30 FlexPen is individualized and determined by a physician based on the patient's specific needs. For patients with type 2 diabetes, a common starting dose is 6 units at breakfast and 6 units at dinner (evening meal). It can also be initiated once daily with 12 units at dinner. Blood glucose monitoring and insulin dose adjustments are recommended to achieve optimal control.
What are the possible side effects of NovoMix 30 FlexPen?
The most common side effect is low blood sugar levels (hypoglycemia), which can manifest as cold sweat, cool pale skin, headache, rapid heartbeat, hunger, temporary vision changes, drowsiness, weakness, nervousness, anxiety, confusion, or difficulty concentrating. Other possible side effects include pain, redness, hives, bruising, swelling, or itching at the injection site. Skin changes like thickening or shrinking of fatty tissue (lipodystrophy) or lumps (cutaneous amyloidosis) can occur at the injection site if rotation is not practiced. Serious allergic reactions are rare but can be life-threatening.
Is NovoMix 30 FlexPen safe during pregnancy or breastfeeding?
If you are pregnant, think you may be pregnant, or are planning a baby, consult your doctor. Insulin needs may change during and after pregnancy. Careful control of diabetes is crucial for the baby's health. There are no restrictions on using NovoMix 30 during breastfeeding, but your doctor may need to adjust your dose.
Can NovoMix 30 FlexPen be taken with other medications?
NovoMix 30 can interact with various medications. Some medicines may decrease insulin requirements (e.g., other antidiabetic drugs, MAOIs, beta-blockers, ACE inhibitors, salicylates, anabolic steroids, sulfonamides), while others may increase them (e.g., oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, danazol). Alcohol can also intensify or reduce the hypoglycemic effect of insulin. Always inform your doctor or pharmacist about all medicines, vitamins, and supplements you are taking.
What precautions should be taken with NovoMix 30 FlexPen?
Always check the insulin label before each injection to avoid accidental mix-ups. Use a new needle for each injection and do not share needles or the pen. Inject under the skin (subcutaneously) in the abdomen, thighs, buttocks, or upper arms, and rotate injection sites regularly to prevent skin changes. Do not use NovoMix 30 in insulin pumps or inject it intravenously or intramuscularly. Monitor blood sugar levels regularly, and carry sugary food or juice to treat low blood sugar. If you have kidney or liver problems, or are elderly, your insulin dose may need adjustment.
What happens if a dose is missed?
If you miss a dose, contact your doctor or diabetes education nurse for instructions. If it's almost time for your next dose, you may be advised to skip the missed dose and continue with your regular schedule. If you remember soon after, you may be able to take it, but ensure you consume carbohydrates within 10 minutes to avoid low blood sugar. Missing doses can lead to high blood sugar levels (hyperglycemia).
How should NovoMix 30 FlexPen be stored?
Unused NovoMix 30 FlexPen should be stored in a refrigerator at 2°C to 8°C, away from the cooling element, and not frozen. Once in use or carried as a spare, it should not be refrigerated and can be stored at room temperature (below 30°C) for a maximum of 4 weeks. Always keep the pen cap on to protect it from light, and do not expose it to excessive heat or light. Discard the pen after 4 weeks, even if there is still medicine left.